Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention.
cardiac implantable device
non-vitamin K antagonist anticoagulant
oral anticoagulation
pocket hematoma
vitamin K antagonist
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
14 Feb 2022
14 Feb 2022
Historique:
received:
29
01
2022
revised:
07
02
2022
accepted:
11
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
There are no data on procedure-related bleeding outcome with non-vitamin K antagonist anticoagulants (NOACs) versus vitamin K antagonist anticoagulants (VKAs) in patients with atrial fibrillation (AF) undergoing cardiac implantable electronic device (CIED) intervention. Our aim was to evaluate whether NOACs have a safety benefit even in terms of fewer hemorrhagic complications at the site of CIED implant. Consecutive AF patients receiving NOACs or VKAs at the time of CIED procedure were included in this observational, retrospective, and monocentric investigation. Primary endpoint was the incidence of post-intervention pocket hematoma. A total of 311 patients were enrolled, 146 on NOACs, and 165 on VKAs. The incidence of pocket hematoma was 3.4% in the NOAC versus 13.3% in the VKA group (
Identifiants
pubmed: 35207259
pii: jcm11040986
doi: 10.3390/jcm11040986
pmc: PMC8876635
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Anatol J Cardiol. 2018 Jan;19(1):67-71
pubmed: 29339702
J Am Coll Cardiol. 2016 Mar 22;67(11):1300-8
pubmed: 26988951
Health Serv Res. 2014 Oct;49(5):1701-20
pubmed: 24779867
N Engl J Med. 2013 May 30;368(22):2084-93
pubmed: 23659733
Europace. 2021 Oct 9;23(10):1612-1676
pubmed: 33895845
Europace. 2021 Jul 18;23(7):983-1008
pubmed: 33878762
N Engl J Med. 2013 Sep 26;369(13):1206-14
pubmed: 23991661
Eur Heart J. 2015 Jul 21;36(28):1805-11
pubmed: 25975659
N Engl J Med. 2011 Sep 15;365(11):981-92
pubmed: 21870978
Eur Heart J. 2018 Nov 21;39(44):3973-3979
pubmed: 30462279
Int J Cardiol. 2018 Aug 15;265:118-124
pubmed: 29885678
Eur Heart J. 2021 Sep 14;42(35):3427-3520
pubmed: 34455430
J Thromb Thrombolysis. 2018 Apr;45(3):386-396
pubmed: 29344822
Europace. 2020 Apr 1;22(4):515-549
pubmed: 31702000
Am J Med. 2016 Oct;129(10):1117-1123.e2
pubmed: 27262782
Thromb Haemost. 2022 Feb;122(2):216-225
pubmed: 33930901
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
N Engl J Med. 2013 Nov 28;369(22):2093-104
pubmed: 24251359
N Engl J Med. 2011 Sep 8;365(10):883-91
pubmed: 21830957
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
N Engl J Med. 2009 Sep 17;361(12):1139-51
pubmed: 19717844
Lancet. 2014 Mar 15;383(9921):955-62
pubmed: 24315724